Perrigo Company PLC’s pending launch of Opill represents more than the first daily oral contraceptive available OTC in the US as well as the introduction of a product likely to be the firm’s top-selling brand.
The Opill launch, planned during the 2024 first quarter, will be the cornerstone of a “mega brand offering solutions across...







